SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012984
Filing Date
2018-05-10
Accepted
2018-05-10 16:31:15
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20180331.htm 10-Q 888035
2 EX-31.1 torc-ex311_10.htm EX-31.1 15482
3 EX-31.2 torc-ex312_9.htm EX-31.2 15711
4 EX-32.1 torc-ex321_8.htm EX-32.1 7838
  Complete submission text file 0001564590-18-012984.txt   4376731

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT torc-20180331.xml EX-101.INS 955369
6 XBRL TAXONOMY EXTENSION SCHEMA torc-20180331.xsd EX-101.SCH 40392
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20180331_cal.xml EX-101.CAL 28856
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20180331_def.xml EX-101.DEF 169914
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20180331_lab.xml EX-101.LAB 295958
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20180331_pre.xml EX-101.PRE 253910
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 18823016
SIC: 2834 Pharmaceutical Preparations